Evidence map›Paper›PMID 41057922›Full record

ArticleHealth research policy and systems2025

Strategies for financial protection for patients with cancer or special diseases in the health system: A scoping review.

Vahid Makhtoomi, Pouran Raeisi, Aziz Rezapour, Hamid Pourasghari, Soudabeh Vatankhah

Abstract readScoping Review
In one paragraph

Article in Health research policy and systems, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Vahid MakhtoomiHealth Management and Economics Research Center, Health Management Research Institute, Iran University of Medical Sciences, Tehran, Iran.
Pouran RaeisiSchool of Health Management and Information Sciences, Iran University of Medical Sciences, Tehran, Iran. raeissi2009@yahoo.com.
Aziz RezapourHealth Management and Economics Research Center, Health Management Research Institute, Iran University of Medical Sciences, Tehran, Iran.
Hamid PourasghariHospital Management Research Center, Health Management Research Institute, Iran University of Medical Sciences, Tehran, Iran.
Soudabeh VatankhahSchool of Health Management and Information Sciences, Iran University of Medical Sciences, Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFinancial protection refers to the health system's ability to protect the population from the financial risk of ill health. Patients with cancer or special diseases are particularly vulnerable to catastrophic health spending and impoverishment, highlighting the urgent need for targeted financial protection strategies. Diseases such as haemophilia, thalassemia, dialysis, renal replacement therapy and multiple sclerosis (MS) are among the list of special diseases in Iran. This scoping review aims to identify existing strategies for financial protection for patients with cancer or special diseases in health systems.

methodsThis scoping review utilized the Arksey and O'Malley framework and used the population-context-concept model to review publications related to financial protection for patients with cancer or special diseases from 2000 to 2024. The data were collected from three databases (PubMed, Institute for Scientific Information (ISI) Web of Science and Scopus) and two search engines (Google and Google Scholar). The keywords included "financial protection," "financial risk protection," "health insurance coverage," "poor people" and "health services."

resultsA total of 4625 articles were found, 17 of which were ultimately included in the final analysis. We identified seven main types of strategies for financial protection in health systems, including purchasing, prepaid mechanisms, financial support, benefits packages, infrastructure and facilities, intersectoral collaboration and economic support.

conclusionPrepaid mechanisms are the most widely used main component of financial protection for patients with cancer and special diseases. Policy-makers and healthcare stakeholders must prioritize adaptable and context-specific solutions that account for local economic, social and healthcare realities.

Indexed as

Delivery of Health CareHealth ExpendituresInsurance, HealthNeoplasmsHumansInsurance CoverageIranPovertyCancerFinancial protectionFinancial risk protectionHealth policyHealth systemScoping reviewSpecial diseases

Identifiers

PMID41057922
PMCPMC12505804

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.